Sleep apnea therapy company Royal Philips has acquired NightBalance, a digital health scale-up company based in the Netherlands. NightBalance has developed a device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.

NightBalance’s Sleep Position Trainer (SPT) was designed as a comfortable and easy to use treatment alternative for people who suffer from positional obstructive sleep apnea. The SPT gently prompts them not to sleep on their back, avoiding the apneas from occurring during sleep. The SPT is CE-marked and is currently marketed in select countries in Europe. It is not available in the United States.

“NightBalance offers a unique, patient friendly solution to treat positional obstructive sleep apnea and positional snoring that is highly complementary to our current offerings,” says John Frank, business leader, sleep & respiratory care at Philips, in a release. “This acquisition will help us further expand our leadership position in the growing home care market, and our ability to deliver integrated solutions that drive efficiencies and improved outcomes.”

Eline Vrijland-van Beest, CEO of NightBalance, says, “We founded NightBalance in 2009 with the ambition to improve the lives of positional apnea patients worldwide. I am proud that our innovation is in good hands with Philips. Their strength in connected sleep therapy solutions and global reach will accelerate the accessibility of the Sleep Position Trainer.”

Pictured: Eline Vrijland-van Beest, CEO and founder of NightBalance, and Egbert van Acht, Chief Business Leader, personal health businesses at Royal Philips.